Ping An Insurance (Group) Company of China, Ltd. (PZX.F)
| Previous close | 4.3700 |
| Open | 4.2700 |
| Bid | 4.2300 x N/A |
| Ask | 4.3100 x N/A |
| Day's range | 4.2700 - 4.3595 |
| 52-week range | 3.5000 - 6.6110 |
| Volume | |
| Avg. volume | 4,565 |
| Market cap | 89.557B |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | 7.27 |
| EPS (TTM) | 0.6000 |
| Earnings date | 22 Aug 2024 |
| Forward dividend & yield | 0.32 (7.31%) |
| Ex-dividend date | 07 Jun 2024 |
| 1y target est | N/A |
PR NewswirePing An Asset Management Up to No. 33 in Top 500 Asset Managers 2024
Ping An Asset Management Co., Ltd. (PAAMC) is ranked 33rd in the world in Top 500 Asset Managers 2024 list from Investment & Pensions Europe (IPE), up three spots from last year. It is ranked number 3 in Asia. PAAMC, established in 2005, is a subsidiary of Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318).
PR NewswirePing An Receives Five "All-Asia Executive Team 2024" Accolades From Institutional Investor Magazine
Institutional Investor magazine has announced the ranking of 2024 Asia (ex-Japan) Executive Team. Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) is delighted to announce that its Board of Directors has been selected as the "Best Company Board"; Xie Yonglin, President and Co-CEO, and Michael Guo, Co-CEO, have been named "Best CEOs", and Zhang Zhichun, Chief Financial Officer, has been named "Best CFO". Addition
PR NewswirePing An Announces Brand Upgrade of "Ping An Family Doctor"
The "Ping An Family Doctor Brand Upgrade Conference" was held in Shanghai recently. Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318 / 82318; SSE: 601318) has upgraded its "Ping An Family Doctor" brand with a one-stop, proactive health management services system and a commitment to providing "proactive health management, chronic disease control, and full disease management" to users.
